Here, the collective genomic and functional evidence of this report provides the first documentation of common coinactivation of multiple members of CKIs in human GBM via genomic codeletion of the CDKN2A/B and CDKN2C loci or concurrent loss of protein expression of p18INK4C and p16INK4A. This evidence concerns the gene CDKN2A and glioblastoma.